Genentech reports results from second Phase III Lucentis® study for the treatment of diabetic macular edema.
- Published in:
- Expert Review of Ophthalmology, 2011, v. 6, n. 2, p. 137
- Publication type:
- Article
Works matching DE "GENETECH AB"
Results: 2
1
2
Avastin's commercial march suffers setback.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 9, p. 879, doi. 10.1038/nbt0910-879
- By:
- Publication type:
- Article